|
|
|
|
|
||
|
|||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
doi: 10.1242/10.1242/jcs.00118
Research Article |
si1,
1 Department of Biophysics and Cell Biology, Medical and Health Science Center, University of Debrecen, POB 39, Debrecen H-4012, Hungary
2 Cell-biophysical Workgroup of the Hungarian Academy of Sciences, University of Debrecen, POB 39, Debrecen H-4012, Hungary
3 Department of Molecular Biology, Max Planck Institute for Biophysical Chemistry, Am Fassberg 11, Göttingen D-37077, Germany
4 Bioimaging Group, Life Sciences Division, Lawrence Berkeley National Laboratory, 1 Cyclotron Road, Berkeley, CA 94720, USA
5 Department of Medicine, Division of Hematology/Oncology, University of California at San Francisco, San Francisco, CA 94143, USA
* Present address: NCI-FCRDC, Boyle Street, Frederick, MD 21702, USA
Author for correspondence (e-mail: szollo{at}jaguar.dote.hu)
Accepted 6 August 2002
The ErbB family of transmembrane receptor tyrosine kinases plays an important role in the pathogenesis of many cancers. The four members of the family, ErbB1-4, form various homo- and heterodimers during the course of signal transduction. A second hierarchical level of molecular associations involving 102-103 molecules, termed large-scale clustering, has also been identified, but the regulatory factors and biological consequences of such structures have not been systematically evaluated. In this report, we describe the states of association of ErbB2 and their relationship to local ErbB3 density and lipid rafts based on quantitative fluorescence microscopy of SKBR-3 breast cancer cells. Clusters of ErbB2 colocalized with lipid rafts identified by the GM1-binding B subunit of cholera toxin. Pixel-by-pixel analysis of fluorescence resonance energy transfer between labeled antibodies indicated that the homoassociation (homodimerization) of ErbB2 was proportional to the local density of ErbB2 and inversely proportional to that of ErbB3 and of the raft-specific lipid GM1. Crosslinking lipid rafts with the B subunit of cholera toxin caused dissociation of the rafts and ErbB2 clusters, an effect that was independent of the cytoskeletal anchoring of ErbB2. Crosslinking also decreased ErbB2-ErbB3 heteroassociation and the EGF- and heregulin-induced tyrosine phosphorylation of Shc. When cells were treated with the anti-ErbB2 monoclonal antibody 4D5 (parent murine version of Trastuzumab used in the immunotherapy of breast cancer), internalization of the antibody was inhibited by crosslinking of lipid rafts, but the antiproliferative activity of 4D5 was retained and even enhanced. We conclude that local densities of ErbB2 and ErbB3, as well as the lipid environment profoundly influence the association properties and biological function of ErbB2.
Key words: ErbB proteins, Lipid rafts, Breast cancer, Fluorescence resonance energy transfer
This article has been cited by other articles:
|
|
 |
|
  D. J. Barr, A. G. Ostermeyer-Fay, R. A. Matundan, and D. A. Brown Clathrin-independent endocytosis of ErbB2 in geldanamycin-treated human breast cancer cells J. Cell Sci., October 1, 2008; 121(19): 3155 - 3166. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. G. Hofman, M. O. Ruonala, A. N. Bader, D. van den Heuvel, J. Voortman, R. C. Roovers, A. J. Verkleij, H. C. Gerritsen, and P. M. P. van Bergen en Henegouwen EGF induces coalescence of different lipid rafts J. Cell Sci., August 1, 2008; 121(15): 2519 - 2528. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. R. Chinni, H. Yamamoto, Z. Dong, A. Sabbota, R. D. Bonfil, and M. L. Cher CXCL12/CXCR4 Transactivates HER2 in Lipid Rafts of Prostate Cancer Cells and Promotes Growth of Metastatic Deposits in Bone Mol. Cancer Res., March 1, 2008; 6(3): 446 - 457. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. M. Pedersen, I. H. Madshus, C. Haslekas, and E. Stang Geldanamycin-Induced Down-Regulation of ErbB2 from the Plasma Membrane Is Clathrin Dependent but Proteasomal Activity Independent Mol. Cancer Res., March 1, 2008; 6(3): 491 - 500. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Yang, M. A. Raymond-Stintz, W. Ying, J. Zhang, D. S. Lidke, S. L. Steinberg, L. Williams, J. M. Oliver, and B. S. Wilson Mapping ErbB receptors on breast cancer cell membranes during signal transduction J. Cell Sci., August 15, 2007; 120(16): 2763 - 2773. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Adachi, T. Nagao, H. I. Ingolfsson, F. R. Maxfield, O. S. Andersen, L. Kopelovich, and I. B. Weinstein The Inhibitory Effect of (-)-Epigallocatechin Gallate on Activation of the Epidermal Growth Factor Receptor Is Associated with Altered Lipid Order in HT29 Colon Cancer Cells Cancer Res., July 1, 2007; 67(13): 6493 - 6501. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Shankaran, H. S. Wiley, and H. Resat Modeling the Effects of HER/ErbB1-3 Coexpression on Receptor Dimerization and Biological Response Biophys. J., June 1, 2006; 90(11): 3993 - 4009. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. E. Shaw, R. F. Epand, R. M. Epand, Z. Li, R. Bittman, and C. M. Yip Correlated Fluorescence-Atomic Force Microscopy of Membrane Domains: Structure of Fluorescence Probes Determines Lipid Localization Biophys. J., March 15, 2006; 90(6): 2170 - 2178. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Benlimame, Q. He, S. Jie, D. Xiao, Y. J. Xu, M. Loignon, D. D. Schlaepfer, and M. A. Alaoui-Jamali FAK signaling is critical for ErbB-2/ErbB-3 receptor cooperation for oncogenic transformation and invasion J. Cell Biol., November 7, 2005; 171(3): 505 - 516. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. S. Lidke, K. A. Lidke, B. Rieger, T. M. Jovin, and D. J. Arndt-Jovin Reaching out for signals: filopodia sense EGF and respond by directed retrograde transport of activated receptors J. Cell Biol., August 15, 2005; 170(4): 619 - 626. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Orr, D. Hu, S. Ozcelik, L. K. Opresko, H. S. Wiley, and S. D. Colson Cholesterol Dictates the Freedom of EGF Receptors and HER2 in the Plane of the Membrane Biophys. J., August 1, 2005; 89(2): 1362 - 1373. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Ghatak, S. Misra, and B. P. Toole Hyaluronan Constitutively Regulates ErbB2 Phosphorylation and Signaling Complex Formation in Carcinoma Cells J. Biol. Chem., March 11, 2005; 280(10): 8875 - 8883. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Bagossi, G. Horvath, G. Vereb, J. Szollosi, and J. Tozser Molecular Modeling of Nearly Full-Length ErbB2 Receptor Biophys. J., February 1, 2005; 88(2): 1354 - 1363. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Nagy, E. Friedlander, M. Tanner, A. I. Kapanen, K. L. Carraway, J. Isola, and T. M. Jovin Decreased Accessibility and Lack of Activation of ErbB2 in JIMT-1, a Herceptin-Resistant, MUC4-Expressing Breast Cancer Cell Line Cancer Res., January 15, 2005; 65(2): 473 - 482. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. R. Gabel, C. Elwell, S. C. D. van Ijzendoorn, and J. N. Engel Lipid Raft-Mediated Entry Is Not Required for Chlamydia trachomatis Infection of Cultured Epithelial Cells Infect. Immun., December 1, 2004; 72(12): 7367 - 7373. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. Hommelgaard, M. Lerdrup, and B. van Deurs Association with Membrane Protrusions Makes ErbB2 an Internalization-resistant Receptor Mol. Biol. Cell, April 1, 2004; 15(4): 1557 - 1567. [Abstract] [Full Text] [PDF]
|
|
